1. Wang, Lisha, Yilmaz, Osman, Veeneman, Brendan A, Dhanasekaran, Saravana M, Mehra, Rohit. 2024. Gene of the month: VSTM2A. In Journal of clinical pathology, 77, 73-76. doi:10.1136/jcp-2023-208839. https://pubmed.ncbi.nlm.nih.gov/38124011/
2. Secco, Blandine, Camiré, Étienne, Brière, Marc-Antoine, Birsoy, Kivanc, Laplante, Mathieu. . Amplification of Adipogenic Commitment by VSTM2A. In Cell reports, 18, 93-106. doi:10.1016/j.celrep.2016.12.015. https://pubmed.ncbi.nlm.nih.gov/28052263/
3. Al Dow, Manal, Silveira, Maruhen Amir Datsch, Poliquin, Audrée, Bilodeau, Steve, Laplante, Mathieu. 2020. Control of adipogenic commitment by a STAT3-VSTM2A axis. In American journal of physiology. Endocrinology and metabolism, 320, E259-E269. doi:10.1152/ajpendo.00314.2020. https://pubmed.ncbi.nlm.nih.gov/33196296/
4. Wang, Lisha, Zhang, Yuping, Chen, Ying-Bei, Dhanasekaran, Saravana M, Mehra, Rohit. . VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney. In The American journal of surgical pathology, 42, 1571-1584. doi:10.1097/PAS.0000000000001150. https://pubmed.ncbi.nlm.nih.gov/30285995/
5. Dong, Yujuan, Zhang, Yanquan, Kang, Wei, Ng, Simon Sm, Yu, Jun. 2019. VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6. In Theranostics, 9, 6517-6531. doi:10.7150/thno.34989. https://pubmed.ncbi.nlm.nih.gov/31588233/
6. Al Dow, Manal, Secco, Blandine, Mouchiroud, Mathilde, Manem, Venkata S K, Laplante, Mathieu. 2025. Loss of VSTM2A promotes adipocyte hypertrophy and disrupts metabolic homeostasis. In Obesity (Silver Spring, Md.), , . doi:10.1002/oby.24224. https://pubmed.ncbi.nlm.nih.gov/39956640/
智鼠故事 
